Mga Batayang Estadistika
| CIK | 889232 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Investor AB (publ)
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| May 21, 2024 |
SC 13D 1 ef20029485sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* LM ERICSSON TELEPHONE COMPANY (Translation of registrant’s name into English) (Name of Issuer) Class B Shares (SEK 5.00 nominal value) (Title of Class of Securities) 294821608** (CUSIP Number) Petra Hedengran Managing Di |
|
| November 6, 2023 |
NDAQ / Nasdaq Inc - 144A / INVESTOR AB - SC 13D/A Activist Investment SC 13D/A 1 ef20014111sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE- |
|
| December 16, 2022 |
NDAQ / Nasdaq Inc / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden +46 8 614 20 00 |
|
| August 26, 2022 |
NDAQ / Nasdaq Inc / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden +46 8 614 20 00 |
|
| June 27, 2022 |
ABB / ABB Ltd. / INVESTOR AB Activist Investment SC 13D/A 1 formsc13da.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New |
|
| June 22, 2021 |
ABB / ABB Ltd. / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| April 24, 2020 |
NDAQ / Nasdaq, Inc. / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden +46 8 614 20 00 |
|
| April 24, 2020 |
EX-99.6 2 ex996.htm EXHIBIT 99.6 EXHIBIT 6 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Shares of Nasdaq, Inc. and further agree that this Joint Filing Agreement shall |
|
| March 6, 2020 |
ABB / ABB Ltd. / INVESTOR AB Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| May 22, 2019 |
ABB / ABB Ltd. / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| February 14, 2019 |
CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M107 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| February 14, 2018 |
SC 13G/A 1 chinacac13gam5dec2017.htm CHINACACHE INTERNATIONAL 13G AMENDMENT NO. 5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M107 (CUSIP Number) December 31, 20 |
|
| February 14, 2017 |
SC 13G/A 1 chinacac13gam4dec2016.htm CHINACACHE INTERNATIONAL HOLDINGS LTD. SC 13G/AM4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M107 (CUSIP Number) December 3 |
|
| May 29, 2015 |
ABB / ABB Ltd. / INVESTOR AB - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 1.03 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| February 17, 2015 |
AGRX / Agile Therapeutics, Inc. / INVESTOR AB - AGILE THERAPEUTICS SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Agile Therapeutics, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00847L100 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 17, 2015 |
CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - AMENDMENT NO. 3 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| May 12, 2014 |
ABB / ABB Ltd. / INVESTOR AB - ABB LTD Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 1.03 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| February 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B 10 3 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| February 14, 2014 |
TNGO / Tangoe, Inc. / INVESTOR AB - AMENDMENT NO. 2 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* TANGOE, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 87582Y108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| February 13, 2013 |
GWAY / Greenway Medical Technologies Inc / INVESTOR AB - GREENWAY SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B 10 3 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 13, 2013 |
TNGO / Tangoe, Inc. / INVESTOR AB - CHINA13GAM2DEC12 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| February 13, 2013 |
TNGO / Tangoe, Inc. / INVESTOR AB - TANGOE13GAM1FEB13 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| May 10, 2012 |
MATR / Mattersight Corp. / INVESTOR AB - SC 13D AMENDMENT 1 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mattersight Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 577097108 (CUSIP Number) Anthony O. Pergola, Esq. Richard Bernstein, Esq. Lowenstein Sandler PC 1251 Avenue of the Americas, 17th Floor New Yo |
|
| February 13, 2012 |
CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - AMENDMENT NO. 1 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| January 18, 2012 |
TNGO / Tangoe, Inc. / INVESTOR AB - TANGOE13GDEC11 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* TANGOE, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 87582Y108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu |
|
| December 27, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* MATTERSIGHT CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 577097108 (CUSIP Number) Anthony O. Pergola, Esq. Richard Bernstein, Esq. Lowenstein Sandler PC 1251 Avenue of the Americas, 18th Floor New Yor |
|
| March 10, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* THE NASDAQ OMX GROUP, inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Alan M. Klein, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 (212) 455-2000 (Name, A |
|
| February 14, 2011 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-l(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. |
|
| February 11, 2011 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary s |
|
| February 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary shares of par value of $0.0001 per share (Title of Class of Securities) G21191 104 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropri |
|
| February 11, 2011 |
Schedule 13G (Amendment No. 3) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 00448Q201 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) C |
|
| February 9, 2011 |
EXHIBIT 4 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of February 7, 2011 by and between each of the sellers named in Schedule I hereto (each, a “Seller,” and, collectively, the “Sellers”), on the one hand, and Investor Trading AB (the “Purchaser”), on the other hand. |
|
| February 9, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* THE NASDAQ OMX GROUP, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Alan M. Klein, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 (212) 455-2000 (Name, A |
|
| January 24, 2011 |
NASDAQ STOCKHOLDERS’ AGREEMENT dated as of December 16, 2010 THE NASDAQ OMX GROUP, INC. INVESTOR AB EXHIBIT 2 EXECUTION VERSION NASDAQ STOCKHOLDERS’ AGREEMENT dated as of December 16, 2010 between THE NASDAQ OMX GROUP, INC. |
|
| January 24, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* THE NASDAQ OMX GROUP, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Alan M. Klein, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 (212) 455-2000 (Name, Ad |
|
| January 24, 2011 |
EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Shares of The NASDAQ OMX Group, Inc. |
|
| January 22, 2010 |
Schedule 13G Amendment No. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 00448Q201 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) Ch |
|
| December 29, 2008 |
Schedule 13G Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 00448Q201 (CUSIP Number) December 18, 2008 (Date of Event Which Requires Filing of this Statement) Ch |
|
| October 20, 2008 |
As filed with the Securities and Exchange Commission on October 20, 2008 Registration No. |
|
| October 20, 2008 |
EXHIBIT 4 Writer’s Direct Dial EMMET, MARVIN & MARTIN, LLP COUNSELLORS AT LAW 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www. |
|
| October 20, 2008 |
AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents One-Half of One (1/2) Share) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR COMMON STOCK, NO PAR VALUE, OF INVESTOR AB (INCORPORATED UNDER THE LAWS OF SWEDEN) The Bank of New York Mellon, as depositary (hereinafter called the “Depositary”), hereby certifies (i) that there have been deposited with the Depositary o |
|
| September 4, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title or Class of Securities) 00448Q201 (CUSIP Number) August 12, 2008 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| February 15, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* KYPHON INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 501577100 (CUSIP Number) December 31, 2004 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
| February 7, 2005 |
WARRANT TO PURCHASE COMMON STOCK OF INNOVATIVE MICRO TECHNOLOGY, INC. EX-99.B 3 dex99b.htm WARRANT TO PURCHASE TO COMMON STOCK Exhibit B THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS (i) A REGISTRATION STATEMENT UNDER THE ACT, |
|
| February 7, 2005 |
WARRANT TO PURCHASE COMMON STOCK OF INNOVATIVE MICRO TECHNOLOGY, INC. EX-99.A 2 dex99a.htm WARRANT TO PURCHASE TO COMMON STOCK Exhibit A THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS (i) A REGISTRATION STATEMENT UNDER THE ACT, |
|
| February 7, 2005 |
EX-99.C 4 dex99c.htm INVESTOR'S RIGHTS AGREEMENT Exhibit C Execution Copy Innovative Micro Technology, Inc. INVESTORS’ RIGHTS AGREEMENT Dated as of January 25, 2005 TABLE OF CONTENTS Page ARTICLE I Definitions 1 1.1 Definition of Terms 1 1.2 Construction 4 ARTICLE II Registration Rights 5 2.1 Request for Registration 5 2.2 Registration Incidental to Company Registration 6 2.3 S-3 Registration 6 2. |
|
| February 7, 2005 |
Innovative Micro Technology, Inc. Voting Agreement EX-99.D 5 dex99d.htm VOTING AGREEMENT Exhibit D Execution Copy Innovative Micro Technology, Inc. Voting Agreement This Voting Agreement (this “Agreement”) is made as of January 25, 2005 by and among Innovative Micro Technology, Inc., a Delaware corporation (the “Company”), the stockholders listed on the signature pages hereto (the “Current Stockholders”) and the investors listed on Schedule I here |
|
| February 7, 2005 |
Innovative Micro Technology, Inc. Right of First Refusal and Co-Sale Agreement EX-99.E 6 dex99e.htm CO-SALE AGREEMENT Exhibit E Execution Copy Innovative Micro Technology, Inc. Right of First Refusal and Co-Sale Agreement This Right of First Refusal and Co-Sale Agreement (this “Agreement”) is made as of January 25, 2005 by and among Innovative Micro Technology, Inc., a Delaware corporation (the “Company”), the stockholders listed on the signature pages hereto (the “Current S |
|
| February 7, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Innovative Micro Technology, Inc. (Name of Issuer) Common Stock, par value $.0001 (Title of Class of Securities) 038-213-104 (CUSIP Number) Investor AB Arsenalsgatatan 8C S-103-32 Stockholm Sweden V7 Tel: 46 8 614 21 50 (Name, Address and Telephone Number of Person Aut |
|
| February 17, 2004 |
SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 1 to SCHEDULE 13D Under the Securities Exchange Act of 1934 AstraZeneca PLC (Name of Issuer) CLASS A SHARES (Title of Class of Securities) G9885J102 (CUSIP Number) Fredrik Lindgren Investor AB Arsenalsgatan 8 c S-103 32 Stockholm Sweden 011-46-8-614-2031 (Name, Address and Telephone Number of Person Auth |
|
| February 11, 2003 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 KYPHON INC. (Name of Issuer) Common Stock (Title of Class of Securities) 501577 10 0 (CUSIP Number) December 31, 2002 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Rule 13 |
|
| November 20, 2002 |
EX-99.(1)(M) 5 a2094139zex-991m.htm EXHIBIT 99.(1)(M) EXHIBIT 99.(1)(M) November , 2002 ISTA Pharmaceuticals, Inc. 15279 Alton Parkway, Suite 100 Irvine, CA 92618 Re: ISTA Pharmaceuticals, Inc.—Lockup Agreement Ladies and Gentlemen: The undersigned understands that ISTA Pharmaceuticals, Inc., a Delaware corporation (the "Company"), has entered into the Common Stock and Warrant Purchase Agreement, |
|
| November 20, 2002 |
QuickLinks - Click here to rapidly navigate through this document SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Amendment No. |
|
| November 20, 2002 |
EX-99.(1)(I) 3 a2094139zex-991i.htm EXHIBIT 99.(1)(I) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.(1)(I) JOINT FILING STATEMENT We, the undersigned, hereby express our agreement that the attached Schedule 13D/A is filed on behalf of each of us. Dated: November 19, 2002 INVESTOR GROWTH CAPITAL LIMITED /s/ MICHAEL OPORTO Michael Oporto Attorney-in-Fact /s/ BORJE EKHO |
|
| November 20, 2002 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.(1)(L) ISTA PHARMACEUTICALS, INC. AMENDMENT TO THE ISTA PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT THIS AMENDMENT TO THE ISTA PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT (the "Amendment") is made as of November 12, 2002, by and among ISTA Pharmaceuticals, Inc., a Delaware corpo |
|
| September 30, 2002 |
EX-99.1(C) 5 a2090302zex-991c.htm EXHIBIT 99.1(C) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.1(c) EXHIBIT C POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR GROWTH CAPITAL LIMITED, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for t |
|
| September 30, 2002 |
EXHIBIT A JOINT FILING STATEMENT EX-99.1(A) 3 a2090302zex-991a.htm EXHIBIT 99.1(A) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.1(a) EXHIBIT A JOINT FILING STATEMENT We, the undersigned, hereby express our agreement that the attached Schedule 13D is filed on behalf of each of us. Dated: September 30, 2002 INVESTOR GROWTH CAPITAL LIMITED /s/ MICHAEL OPORTO Michael Oporto Attorney-in-Fact /s/ BORJE E |
|
| September 30, 2002 |
EX-99.1(B) 4 a2090302zex-991b.htm EXHIBIT 99.1(B) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.1(b) EXHIBIT B POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR AB, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for the limited purpose o |
|
| September 30, 2002 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (RULE 13d-101) QuickLinks - Click here to rapidly navigate through this document SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. |
